Press Releases

Apr 6, 2016

PharmaCyte Biotech's CEO Explains How New Clinical Trial Design Changed the GMP Certification Process

Mar 31, 2016

PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration

Mar 15, 2016

PharmaCyte Biotech Discusses Protection Strategy for Cancer and Diabetes Therapies

Mar 3, 2016

PharmaCyte Biotech Reports on Audit of Live-Cell Encapsulation Facility by Chamow & Associates

Mar 1, 2016

PharmaCyte Biotech Addresses Development of Targeted Cannabinoid Chemotherapy

Feb 26, 2016

PharmaCyte Biotech Pancreatic Cancer Treatment to Target Recently Identified Forms of Pancreatic Cancer

Feb 24, 2016

PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer

Feb 22, 2016

PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial

Feb 10, 2016

Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech

Feb 8, 2016

Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment